M
Mars Semiconductor Corp
TPEX:6708
Mars Semiconductor Corp
TPEX:6708
Price:
37.9
TWD
-0.26%
Market Closed
Market Cap:
NT$1.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
M
|
Mars Semiconductor Corp
TPEX:6708
|
TW |
|
N
|
New Ray Medicine International Holding Ltd
HKEX:6108
|
CN |
|
Immedia Group PLC
LSE:IME
|
UK |
|
B
|
Biolog Device Co Ltd
KOSDAQ:208710
|
KR |
Balance Sheet
Balance Sheet Decomposition
Mars Semiconductor Corp
Mars Semiconductor Corp
Balance Sheet Decomposition is not available for
Mars Semiconductor Corp
Mars Semiconductor Corp
Balance Sheet
Mars Semiconductor Corp
Mars Semiconductor Corp
Currency: TWD
| Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
182
|
217
|
218
|
225
|
236
|
239
|
380
|
275
|
|
| Cash |
119
|
113
|
163
|
57
|
108
|
123
|
0
|
0
|
|
| Cash Equivalents |
63
|
104
|
55
|
168
|
128
|
116
|
380
|
275
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
35
|
67
|
|
| Total Receivables |
23
|
17
|
19
|
17
|
41
|
28
|
57
|
48
|
|
| Accounts Receivables |
23
|
17
|
19
|
16
|
41
|
28
|
57
|
48
|
|
| Other Receivables |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Inventory |
44
|
69
|
43
|
40
|
35
|
89
|
57
|
40
|
|
| Other Current Assets |
45
|
105
|
83
|
63
|
60
|
53
|
8
|
5
|
|
| Total Current Assets |
294
|
408
|
363
|
345
|
371
|
409
|
537
|
437
|
|
| PP&E Net |
2
|
1
|
1
|
11
|
11
|
5
|
14
|
12
|
|
| PP&E Gross |
2
|
1
|
1
|
11
|
11
|
5
|
0
|
0
|
|
| Accumulated Depreciation |
2
|
3
|
4
|
4
|
5
|
5
|
0
|
0
|
|
| Intangible Assets |
21
|
12
|
12
|
11
|
13
|
11
|
3
|
1
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
|
| Other Long-Term Assets |
1
|
1
|
1
|
1
|
9
|
9
|
10
|
10
|
|
| Total Assets |
318
N/A
|
423
+33%
|
378
-11%
|
368
-3%
|
405
+10%
|
436
+8%
|
565
+30%
|
461
-18%
|
|
| Liabilities | |||||||||
| Accounts Payable |
18
|
26
|
16
|
11
|
20
|
21
|
7
|
9
|
|
| Accrued Liabilities |
8
|
10
|
10
|
11
|
10
|
15
|
4
|
0
|
|
| Short-Term Debt |
45
|
119
|
70
|
50
|
50
|
50
|
10
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
4
|
12
|
4
|
6
|
4
|
|
| Other Current Liabilities |
9
|
11
|
10
|
8
|
16
|
17
|
30
|
20
|
|
| Deferred Revenue |
1
|
0
|
0
|
0
|
7
|
0
|
0
|
0
|
|
| Total Current Liabilities |
80
|
167
|
106
|
84
|
107
|
108
|
57
|
32
|
|
| Long-Term Debt |
0
|
0
|
0
|
6
|
22
|
25
|
22
|
7
|
|
| Other Liabilities |
4
|
4
|
4
|
4
|
4
|
12
|
13
|
5
|
|
| Total Liabilities |
84
N/A
|
171
+104%
|
110
-36%
|
94
-15%
|
133
+42%
|
144
+8%
|
92
-36%
|
44
-52%
|
|
| Equity | |||||||||
| Common Stock |
174
|
205
|
224
|
239
|
244
|
256
|
290
|
290
|
|
| Retained Earnings |
43
|
27
|
24
|
15
|
9
|
30
|
49
|
7
|
|
| Additional Paid In Capital |
17
|
20
|
20
|
20
|
20
|
8
|
135
|
135
|
|
| Other Equity |
0
|
0
|
0
|
0
|
1
|
2
|
1
|
1
|
|
| Total Equity |
235
N/A
|
252
+7%
|
268
+6%
|
274
+2%
|
272
-1%
|
292
+7%
|
472
+62%
|
416
-12%
|
|
| Total Liabilities & Equity |
318
N/A
|
423
+33%
|
378
-11%
|
368
-3%
|
405
+10%
|
436
+8%
|
565
+30%
|
461
-18%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
24
|
25
|
25
|
26
|
26
|
26
|
29
|
29
|
|
Switch to:
Switch to:
Continue Research
Discover More
